LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival - Wikidata - awgldk - TriplyDB

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

http://www.wikidata.org/entity/Q58425803

about

Oligodendrogenesis in the normal and pathological central nervous system Astrocytes promote myelination in response to electrical impulses The multifaceted role of astrocytes in regulating myelination The role of neurotrophins in multiple sclerosis-pathological and clinical implications Promoting myelin repair and return of function in multiple sclerosis A herpes simplex virus-derived replicative vector expressing LIF limits experimental demyelinating disease and modulates autoimmunity The Transcriptional Activator Krüppel-like Factor-6 Is Required for CNS Myelination Protective role of STAT3 in NMDA and glutamate-induced neuronal death: negative regulatory effect of SOCS3 Exogenous leukemia inhibitory factor (LIF) attenuates retinal vascularization reducing cell proliferation not apoptosis Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.Emerging therapies in multiple sclerosis.From fish to man: understanding endogenous remyelination in central nervous system demyelinating diseases.Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.Changes in NG2 cells and oligodendrocytes in a new model of intraspinal hemorrhage.Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve.SOCS1 and SOCS3 in the control of CNS immunity Transplantation of ciliary neurotrophic factor-expressing adult oligodendrocyte precursor cells promotes remyelination and functional recovery after spinal cord injury.The pathogenesis of murine coronavirus infection of the central nervous system.Vaginally administered PEGylated LIF antagonist blocked embryo implantation and eliminated non-target effects on bone in mice.Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: role of IGF-2 Leukemia inhibitor factor promotes functional recovery and oligodendrocyte survival in rat models of focal ischemia.Leukemia inhibitory factor protects axons in experimental autoimmune encephalomyelitis via an oligodendrocyte-independent mechanism.IL-11 regulates autoimmune demyelination EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE)Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination.Neuroprotective effect of leukemia inhibitory factor on antimycin A-induced oxidative injury in differentiated PC12 cells.Targeting oligodendrocyte protection and remyelination in multiple sclerosis.Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination Therapeutic effect of vasoactive intestinal peptide on experimental autoimmune encephalomyelitis: down-regulation of inflammatory and autoimmune responses.Disease-modifying therapies in multiple sclerosis: an update on recent and ongoing trials and future strategies.Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis.Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11.RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injury Continued administration of ciliary neurotrophic factor protects mice from inflammatory pathology in experimental autoimmune encephalomyelitis.Remyelinating and neuroprotective treatments in multiple sclerosis.Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury.Glucocorticoids: protectors of the brain during innate immune responses.Regulation of neurokine receptor signaling and trafficking Role of glial 14-3-3 gamma protein in autoimmune demyelination.Perspectives on neuroreparative therapies for treating multiple sclerosis.

P2860

Q21129352-77AB03CB-64B0-4886-8BCC-4DE16302CDD1 Q24547572-0A94F559-4F78-4DD4-A1C6-4E8FE78E0C94 Q26764727-5BBA0377-F4CB-4F94-A5B6-DA246F6CCF6D Q26849274-35FEDD43-7771-48E1-907B-8B98944C1DF2 Q26862803-3525DF42-6E69-4DED-A17A-24B97DFC7113 Q27319470-4493234F-5BD0-4E2C-BF22-033520C1079E Q27342581-F95ACFC5-F9FB-486A-A684-DBC1F2ABC9B4 Q28485407-60A18579-5D12-442B-A591-344AFFF9CF23 Q28566217-BA09BAC2-9DFD-44E0-8493-1D0328CFC98B Q30479247-F7062D7E-3671-4683-A541-1980DD2584BD Q31015100-D1994043-A18F-48B6-9121-7A758620315E Q31155244-2A202445-2172-4A24-99C3-960439078DE7 Q33514833-55E2D91B-3B5B-494A-8EEA-4199260F3E75 Q33678177-8B71FF9A-C8FF-47DB-AA56-273A08C9CB7D Q33692583-14DAD0D8-4C61-42B7-9BDC-165D2D3B8239 Q33717795-A0FF3945-6B3E-4B26-BF30-73ADBA26F71C Q33720720-B175E683-FAE0-4CCC-B2E5-76A5B95EC8C6 Q33779927-B432B105-FE8E-426A-BF13-3DF86F405E0F Q33911059-19998EC8-360B-40A8-B89C-F8F18002CD87 Q34143138-8055D7E8-32BD-4DD2-81B9-C05CAAC6DF65 Q34308344-258CB61C-748A-4245-A628-13AFC5AD9F73 Q34450780-3E619ADC-711F-485D-ACE5-FB1CC5FE43F2 Q34522058-1BB180F1-285B-49B2-81A1-FE85CA4F80A2 Q34580168-251AA81C-21BD-40CE-A59B-A0768CBB9720 Q34650995-CF538547-9990-41C2-A621-FE038EE1AB5E Q34699493-ED6D41FE-51CB-4768-9D18-9DA65C5FA7EB Q34782075-BDDA4AF1-790A-4E2A-94B0-DDF9EFAB3922 Q34960361-37BA63F6-4589-4EFF-8251-699EC32BA12D Q35088106-05444664-7632-46D6-BAA9-4ADA9D77D7FA Q35094706-B60D6D0D-1752-4E5D-900E-7F899B129FBB Q35097450-ED516CB5-B867-4144-8AE8-8EF2735859BE Q35188004-955C764E-86FF-4AE2-9D4B-452F0F068B3E Q35209243-7F3263B5-FB08-4F9D-9957-C4878D282F28 Q35221952-88AA5032-ACED-492D-8283-B9ADCF54D677 Q35753458-6CB05F32-F9DD-4310-80D1-A19C5EA0EB66 Q35780674-92324D8F-1DC4-430F-AB2D-DEF08CC82D99 Q35943567-F740A577-2236-47E9-A33C-88BA7922AE1D Q35954728-D8E0EA3C-9451-40CC-88D5-0A1C730ED554 Q36127346-68E2C68B-6C62-4A20-AF81-82D2722FD5F0 Q36443617-15FA9964-9E33-4E2E-A474-8436505FB1B3

P2860

LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival

http://www.wikidata.org/entity/Q58425803

description

im Juni 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 01 June 2002

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2002

@uk

name

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@en

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@nl

type

label

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@en

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@nl

prefLabel

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@en

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@nl

P1433

Q58425803-FE4B5F5A-BE68-4CAF-989D-C7A7B35AE6CC

P1476

Q58425803-410AE0CA-AF70-4A49-934C-95DE295E00F9

P2093

Q58425803-01BBF796-2475-41D6-89AA-102F540FDEF7

Q58425803-11894FED-E5C6-4C63-8991-EC437597A0FC

Q58425803-2E1DC9CD-707A-4026-A4CC-3ABFF9E340DB

Q58425803-921A6A93-E201-4BD5-906D-5D31783C85B6

Q58425803-931FD825-0E78-4C33-9CFA-46F701C6B4AE

Q58425803-EA93A3AA-5198-4FB6-BC80-132167BFB737

Q58425803-FEA63C8D-95EF-4DE1-A81E-C62698C8AE63

P2888

Q58425803-70F917C1-2590-4E20-BEA5-D2250E25AC45

P304

Q58425803-F0C1DD51-9FF4-46A5-AABD-A56B7A4CFAEF

P31

Q58425803-E8CF01A9-A9D6-4482-9088-88DAB84045B2

P356

Q58425803-F6012823-8919-47CC-BA63-2B9EB1C439EC

P407

Q58425803-CF1A8914-296F-429D-BEBD-9BEAD448DBC3

P433

Q58425803-CAD373B4-A3C8-4099-9D0C-8253BE7205D4

P478

Q58425803-9823E288-7846-4158-A8DF-2BD3B44255C5

P50

Q58425803-0713F827-0030-4D60-9E48-8A590E8D16A2

Q58425803-2D0645D7-736E-4AC1-A830-06EE9F6C6213

Q58425803-3352FB4A-4715-49EE-BA7A-90C47135AE00

Q58425803-6F87972B-EBCC-4F47-9231-E8A5A04FC162

Q58425803-E203422D-59E0-4AA8-8173-6862F73A86FA

P577

Q58425803-95D34653-0C16-4D93-A586-E8BEC8933F01

P6179

Q58425803-B4C7C9F6-98E3-4A38-85B1-6B0A69FA4DA1

P698

Q58425803-62E8BDA7-C3B7-4D96-B3ED-D724AF0DFF87

P921

Q58425803-CA51F3C6-57C8-474F-ACD4-B5D8ED5085FA

P356

P1433

Nature Medicine

P1476

LIF receptor signaling limits ...... ncing oligodendrocyte survival

@en

P2093

Fiona Chionh

http://www.w3.org/2001/XMLSchema#string

Hubertus Hochrein

http://www.w3.org/2001/XMLSchema#string

Jian-Guo Zhang

http://www.w3.org/2001/XMLSchema#string

Kylie A Shipham

http://www.w3.org/2001/XMLSchema#string

Merja Soilu-Hanninen

http://www.w3.org/2001/XMLSchema#string

Perry F Bartlett

http://www.w3.org/2001/XMLSchema#string

Steven Petratos

http://www.w3.org/2001/XMLSchema#string

P2888

P304

613-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM0602-613

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Helmut Butzkueven

Trevor Kilpatrick

P577

2002-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046931575

http://www.w3.org/2001/XMLSchema#string

P698

12042813

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte